SEMA3F and breast cancer: In addition, TIMP2, whose secretion is enhanced by SEMA3F, has been previously described as a key protein involved in MMP2 and MMP14 activation, is specifically linked to the induction of migration in BC cells [79] and is positively correlated with poor prognosis in BC patients [80].